期刊文献+

Herceptin联合顺铂对高表达Her-2/neu卵巢癌体外作用的实验研究 被引量:2

Primary study on herceptin combined with DDP to the vivo action for culture of human ovarian cancer with Her-2/neu overexpression
原文传递
导出
摘要 目的筛选高表达Her-2/neu的卵巢癌细胞株,观察Herceptin联合顺铂(DDP)对该细胞株体外生长的抑制作用。方法采用反转录-聚合酶链反应技术,检测人卵巢癌细胞株3AO,SKOV3,OVCARHer-2/neu的表达情况,筛选出高表达Her-2/neu的人卵巢癌细胞株。采用四甲基偶氮唑蓝(MTT)法测定Herceptin,DDP以及联合用药对高表达Her-2/neu的人卵巢癌细胞株体外生长抑制率并进行比较。结果人卵巢癌细胞株SKOV3Her-2/neu呈高表达;Herceptin可有效抑制SKOV3的生长,具有浓度依赖性(P=0.001),联合用药组的生长抑制率为79.41%,明显高于二者单独作用(P=0.0001)。结论人卵巢癌细胞株SKOV3Her-2/neu呈高表达。Herceptin,DDP均能有效抑制SKOV3的生长,联合用药组疗效更佳。 Objective To select human ovarian carcinoma cell strain which overexpressed Her-2/neu and study the inhibition action of herceptin combined with DDP on the cell strain cultured in vitro. Methods Human ovarian cancer cell strain (3AO,SKOV3,OVCAR) were cultu,ed in vitro. Reverse transcription polymerase chain reaction(RT-PCR) and 4, 5-dimethyl thiazole (MTT) were applied to assay the expression of Her-2/neu,and the growth inhibiting rates of various concentration of herceptin, DDP, herceptin combined with DDP on human ovarian carcinoma cell strain which ove,expressed Her-2/neu. Results Her-2/neu was overexpressed only in human ovarian carcinoma cell strain SKOV3; The g,owth of SKOV3 can be significantly inhibited by herceptin and DDP with concentration dependence(P = 0.001), the combination effect was significantly higher than simple one (P =0.0001). Conclusion Her-2/neu was overexpressed only in human ovarian carcinoma cell strain SKOV3; Herceptin and DDP can inhibit the growth of SKOV3 effectively with concentration dependence,and the growth inhibiting rate of herceptin combined with DDP to SKOV3 was higher than simple effect.
出处 《肿瘤研究与临床》 CAS 2006年第5期298-300,共3页 Cancer Research and Clinic
关键词 HERCEPTIN 顺铂 HER-2/NEU 卵巢癌 Herceptin DDP Ovarian cancer Her-2/neu
  • 相关文献

参考文献2

二级参考文献10

  • 1孙燕.乳腺癌的内科治疗现代诊断与治疗[M].北京:北京医科大学和中国协和医科大学联合出版社,1988,9.193-196.
  • 2Baselga J, Tripathy D, Mendelsohn J, et al, Phase II study of weekly intravenous recombiTmnt humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. JClin Oncol, 1996, 14: 737-744.
  • 3Vogel CL, Cobleigh MA, Tripalhy D, et al. First-line herceptin monolherapy in metastatic breast cancer. Oncology 2001,61 ( Suppl2).37-42.
  • 4Fomier M, Esteva FJ, Seidman AD. Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer. Semin-Oncol,2000, 27: 38-45.
  • 5Baselga J, Norton L, Albanell J, et al. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res, 1998, 58: 2825-2831.
  • 6许凯黎,中华医学杂志,1995年,75卷,233页
  • 7张国玲,中华妇产科杂志,1994年,29卷,401页
  • 8许凯黎,上海医学,1992年,15卷,461页
  • 9周爱萍,冯奉仪.乳腺癌靶向治疗:Herceptin的研究进展[J].国外医学(肿瘤学分册),2000,27(3):167-170. 被引量:18
  • 10宋海珠.Herceptin治疗转移性乳腺癌的研究进展[J].中国肿瘤生物治疗杂志,2002,9(2):144-145. 被引量:14

共引文献22

同被引文献15

  • 1何以丰,徐丛剑,冯令达.HER-2/neu与上皮性卵巢癌术后生存率相关性的Meta分析[J].中国循证医学杂志,2007,7(6):420-432. 被引量:7
  • 2Atalay G, Cardoso F, Awada A, et al. Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR)' family and its down stream effectors in breast cancer [J] . Ann Oncol, 2003, 14 (9) : 1346.
  • 3Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays: what will they bring to molecular profiling of tumor specimens [J]. Nat Med, 1998, 4 (7): 844.
  • 4Kunter E, Cermik H, lsitmangil T, et al. Prevalence and prognostic value of c - erbB - 2 expression in non - small cell lung cancer (NSCLC) [J] .Neopt 2003, 50 (4): 257.
  • 5Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER - 2/ neu proto - oncogene in human breast and ovarian cancer [ J ] . Science, 1989, 244 (4905): 707.
  • 6Fedip E, DelCampo JM, Rubio D, et al. Overexpression of C - erbB - 2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy [ J ] . Oncology & Radiotherapy, 1995, 75 (8) : 2147.
  • 7Wen CC, Cheng SA, Hsuen SP, et al. SV40 T/t -common polypeptide specifically induces apoptosis in human cancer cells that overexpress HER2/neu [J]. Cancer Res, 2006, 66 (11) : 5847.
  • 8Serrano - Olvera A, Duenas - Gonzalez A, Gallardo - Rincon D, et al. Prognostic, predictive and therapeutic implications of HER - 2 in invasive epithelial ovarian cancer [ J]. Cancer Treat Rev, 2006, 32 (3) : 180.
  • 9李蓉,朱晓玲,田桂兰.C-erbB_2、p53基因及PCNA在上皮性卵巢癌中的表达及临床意义[J].重庆医科大学学报,2007,32(12):1285-1287. 被引量:7
  • 10张玉松,傅晋祥,周丽英,周剑影,郭晓葵.肿瘤坏死因子相关凋亡诱导配体与赫赛汀联用对C-erbB2过表达的乳腺癌SKBR-3细胞株的影响[J].苏州大学学报(医学版),2007,27(1):38-40. 被引量:3

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部